Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial-Reference-Cited by-同舟云学术

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

Published:2023-04 Issue: Volume:183 Page:24-37
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

TAO Yungan,Sun Xu-Shan,Pointreau Yoann,Le Tourneau Christophe^ORCID,Sire Christian^ORCID,Kaminsky Marie-Christine^ORCID,Coutte Alexandre,Alfonsi Marc,Calderon Benôit,Boisselier Pierre,Martin Laurent,Miroir Jessica,Ramee Jean-Francois,Delord Jean-Pierre,Clatot Florian,Rolland Frederic,Villa Julie,Magne Nicolas,Elicin Olgun^ORCID,Gherga Elisabeta,Nguyen France,Lafond Cédrik,Bera Guillaume^ORCID,Calugaru Valentin,Geoffrois Lionnel,Chauffert Bruno,Damstrup Lars,Crompton Philippa,Ennaji Abdallah,Gollmer Kathrin,Nauwelaerts Heidi,Bourhis Jean

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J Clin,2021

2. Head and neck cancer. v1,2022

3. Multidisciplinary management of locally advanced SCCHN: optimizing treatment outcomes;Ang;Oncologist,2008

4. Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01);Lee;BMC Cancer,2020

5. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Machiels;Ann Oncol,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours;Frontiers in Oncology;2024-01-30

2. Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design;Future Oncology;2024-01-10

3. Letter to the Editor: SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses;Cellular Immunology;2024-01

4. Study on the regulatory mechanism and experimental verification of Ardisia crenata for the treatment of head and neck squamous cell carcinoma;2023-12-07

5. IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma;Medical Oncology;2023-11-14